News feed

Mark Clein, Co-Founder and CEO of Precision Medicine Group, delivers the keynote address for BioTrinity 2020

Written by Precision Experts | May 17, 2020 2:01:00 PM

You can view his address at your convenience here. In the course of his presentation you will hear:

  • The ways in which digital technology is transforming patient care and impacting clinical trials
  • What new breakthroughs are on the horizon
  • How precision medicine continues to advance and affect patient treatment and outcomes